These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa. Chikandiwa A, Kelly H, Sawadogo B, Ngou J, Pisa PT, Gibson L, Didelot MN, Meda N, Weiss HA, Segondy M, Mayaud P, Delany-Moretlwe S, HARP Study Group. PLoS One; 2018; 13(5):e0196018. PubMed ID: 29715305 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study. Kelly HA, Chikandiwa A, Sawadogo B, Gilham C, Michelow P, Lompo OG, Omar T, Zan S, Magooa P, Segondy M, Nagot N, Meda N, Delany-Moretlwe S, Mayaud P, HARP Study Group. PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957 [Abstract] [Full Text] [Related]
7. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study. Wang Q, Ma X, Zhang X, Ong JJ, Jing J, Zhang L, Wang LH. Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414 [Abstract] [Full Text] [Related]
12. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Firnhaber C, Zungu K, Levin S, Michelow P, Montaner LJ, McPhail P, Williamson AL, Allan BR, Van der Horst C, Rinas A, Sanne I. Acta Cytol; 2009 Mar; 53(1):10-7. PubMed ID: 19248549 [Abstract] [Full Text] [Related]
13. Cervical intraepithelial neoplasia (CIN) in African women living with HIV: role and effect of rigorous histopathological review by a panel of pathologists in the HARP study endpoint determination. Doutre S, Omar T, Goumbri-Lompo O, Kelly H, Clavero O, Zan S, Chikandiwa A, Sawadogo B, Delany-Moretlwe S, Costes V, Mayaud P, Segondy M, HARP Study Group. J Clin Pathol; 2018 Jan; 71(1):40-45. PubMed ID: 28600294 [Abstract] [Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [Abstract] [Full Text] [Related]
18. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL. BMC Cancer; 2009 Aug 07; 9():275. PubMed ID: 19664216 [Abstract] [Full Text] [Related]
19. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, Smith JS, Jiang CQ, Mei RB, Wang XG, Li ZA, Qiao YL. Asian Pac J Cancer Prev; 2012 Aug 07; 13(1):91-6. PubMed ID: 22502720 [Abstract] [Full Text] [Related]